4128 On Other Exchanges
Symbol
Exchange
4128 is not on other exchanges.

microbio co ltd (4128) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MICROBIO CO LTD (4128)
\

Related News

No related news articles were found.

microbio co ltd (4128) Related Businessweek News

No Related Businessweek News Found

microbio co ltd (4128) Details

Microbio Co., Ltd. researches and develops, manufactures, and sells novel therapeutics in Taiwan. Its marketed products include Chemo Young, an oral adjunct drug to treat fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, an oral combination botanical drug to treat primary dysmenorrhea and iron-deficiency anemia. The company also offers health care products and supplements, and herbal medicines. Its products under development comprise MB6 that is in Phase III clinical trial to treat colorectal cancer; MB110, which is in Phase I clinical trial for the treatment of Hepatitis C; ON101 that is in Phase III clinical trial for chronic diabetic wound healing; OB318, which is in Phase I clinical trials to treat liver cancer; FB825 that is in Phase II clinical trial for the treatment of allergy/asthma; FB317, which is in Phase I clinical trial for the treatment of allergy/asthma; and FB704A that is in preclinical studies to treat rheumatoid arthritis, as well as FB121, which is in preclinical studies for the treatment of AIDS. The company was founded in 2000 and is based in Taipei, Taiwan.

Founded in 2000

microbio co ltd (4128) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

microbio co ltd
Microbio Co., Ltd. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-10-2018 09:30 AM

Microbio Co., Ltd. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-10-2018 09:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States.

Microbio Co., Ltd., Annual General Meeting, Jun 26, 2017

Microbio Co., Ltd., Annual General Meeting, Jun 26, 2017.

Microbio Co., Ltd. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 09:30 AM

Microbio Co., Ltd. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 09:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Wayne Tan, Chairman Advisor.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4128 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4128.
View Industry Companies
 

Industry Analysis

4128

Industry Average

Valuation 4128 Industry Range
Price/Earnings 15.8x
Price/Sales 6.1x
Price/Book 1.1x
Price/Cash Flow 15.8x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MICROBIO CO LTD, please visit www.microbio.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.